Rowland Bryan T.R.

General Counsel sells 43.2K shares for $1.6M, reducing stake by 99.7%; stock down 22.6% in 30 days

Rowland Bryan T.R., General Counsel at Vertex, Inc., filed 2 separate sales totaling 43,228 shares for $1,555,515.19 on 2025-03-19, liquidating essentially his entire stake (99.7% reduction, leaving 132 shares post-transaction). The transactions occurred at blended average price of $35.98, while the stock has since fallen to $35.71 current price and declined 22.6% over the past 30 days and 33.3% over 90 days from a 52-week high of $58.95. His prior trades at VERX show no well-timed sells: 5 prior trades achieved 90-day returns ranging from +10.9% to +38.3%, meaning the stock rose after each sale—the pattern of a seller consistently exiting before rallies rather than before declines. Given the company's full-year unprofitability despite recent quarter revenue of $170.4M and 16.5% annual growth, context matters for interpreting a near-total departure by the top legal officer at a $941.3M market-cap firm during a sharp downtrend.

General Counsel Rowland sold all 38,176 shares at blended average $35.71; complete exit from VERX position.

Rowland Bryan T.R., General Counsel, executed 2 separate sales totaling 38,176 shares for $1,363,228.62, completely eliminating his holdings in Vertex. The timing occurs near the 52-week high ($40.01), with the stock now down 10.5% from peak and having declined 10.5% over the last 30 days. His prior trades at VERX show a pattern of unsuccessful timing: 3 prior sells all resulted in positive 90-day returns (ranging +10.9% to +12.2%), meaning the stock rose after each sale—a 0% well-timed rate at this ticker. His cross-ticker track record similarly shows avg 90d return of +11.5% after sells with a 0.00% well-timed rate. The company remains unprofitable on a full-year basis despite posting $161.1M revenue growth at +16.4% annually and trading at a P/E of 47.75. This complete exit by the General Counsel, exiting near-peak valuations and following a historical pattern of poor sell timing at this specific ticker, may warrant investor attention given the elevation in valuation multiples relative to profitability.